Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms

January 28, 2015 updated by: Technical University of Munich

Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms.

Patients with atypical symptoms of objectified gastroesophageal reflux disease will be treated by full-thickness gastroplication and the effect of this intervention will be measured by questionnaires and clinical diagnostics (for example pH/MII).

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linz, Austria, 4010
        • Not yet recruiting
        • Krankenhaus der Barmherzigen Schwestern Linz, Klinik für Allgemein- und Viszeralchirurgie
        • Contact:
        • Contact:
        • Principal Investigator:
          • Georg Spaun, PD Dr. med.
        • Principal Investigator:
          • Oliver Koch, PD Dr. med.
      • Ludwigsburg, Germany, 71640
        • Recruiting
        • Klinikum Ludwigsburg, Klinik für Innere Medizin, Gastroenterologie, Hämato-Onkologie, Diabetologie und Infektiologie
        • Contact:
        • Contact:
        • Principal Investigator:
          • Carel Kaka, Prof. Dr. med.
        • Principal Investigator:
          • Arthur Schmidt, Dr. med.
    • Bavaria
      • München, Bavaria, Germany, 81675
        • Recruiting
        • Klinikum rechts der Isar der Technischen Universität München, II. Med. Klinik und Poliklinik
        • Contact:
        • Contact:
        • Principal Investigator:
          • Monther Bajbouj, PD Dr. med.
        • Principal Investigator:
          • Simon Nennstiel, Dr. med.
        • Sub-Investigator:
          • Stefan von Delius, PD Dr. med.
      • München, Bavaria, Germany, 81675
        • Recruiting
        • Klinikum rechts der Isar der Technischen Universität München, Klinik und Poliklinik für Chirurgie
        • Contact:
        • Principal Investigator:
          • Hubertus Feußner, Prof. Dr. med.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 18 years and 80 years
  • symptomatic, objectified reflux disease (atypical symptoms - Montreal-classification)

Exclusion Criteria:

  • Rejection of study-participation,
  • Pregnancy
  • negative pH-metry / impedance monitoring (non-objectified reflux)
  • hiatal hernia bigger than 2 cm or gastroesophageal junction > Hill IV classification
  • different potential reasons for atypical symptoms like heterotopic gastric mukosa in the cervikal esophagus
  • Achalasia, esophageal spasm
  • Presence of contraindications for the interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Atypical GERD syptoms treated with GERD-X
Patients treated by means of full-thickness gastroplication
Endoscopic full-thickness gastroplication wit the GERD-X device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Reflux Symptom index
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Monther Bajbouj, PD Dr. med., Klinikum rechts der Isar, II. Med
  • Principal Investigator: Simon Nennstiel, Dr. med., Klinikum rechts der Isar, II. Med

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Anticipated)

December 1, 2015

Study Registration Dates

First Submitted

July 2, 2014

First Submitted That Met QC Criteria

July 3, 2014

First Posted (Estimate)

July 4, 2014

Study Record Updates

Last Update Posted (Estimate)

January 29, 2015

Last Update Submitted That Met QC Criteria

January 28, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atypical Gastroesophageal Reflux Symptoms

Clinical Trials on Full-thickness gastroplication (GERD-X)

Subscribe